Technology

  • Biomarker discovery through Multi-omics analysis
    Lepidyne utilized various genetic data such as whole genome, transcriptome, epigenome and clinical information to identify biomarker for HCC detection.
    MORE
  • Biomarker discovery based on Machine learning
    We have a technology to discover liver cancer-specific biomarkers with the optimal detection performance based on artificial intelligence technique called machine learning using big data.
    MORE
  • The mission Liquid biopsy
    We are developing a technology to diagnose cancer from blood and not from inconvenient tissue biopsy.
    MORE

About LepiDyne

MORE

Product

We will be the leaders in the fields of cancer diagnostics with our cutting-edge technologies.

Support